In 2025, the United States finds itself at a crossroads in public health policy. Deep federal budget reductions have forced significant CDC news cuts, threatening programs designed to prevent chronic illnesses and monitor infectious diseases. Amid these financial constraints, the re-emergence of ivermectin covid discussions has intensified debates about alternative...